Related Experiment Video
Updated: Apr 14, 2026
09:43
Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering
Published on: November 22, 2019
6.9K
Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine.
1Capish Nordic AB, Stortorget 9, 211 22 Malmö, Sweden.
Pharmaceutical Medicine
|April 17, 2015
Summary
The pharmaceutical industry faces declining productivity and rising costs. Big Data initiatives offer a new approach to integrate life science data, potentially improving efficiency and enabling sustainable growth.
Area of Science:
- Pharmaceutical industry
- Life sciences
- Healthcare economics
Background:
- Declining productivity and increasing costs in the pharmaceutical sector over the past two decades.
- Stagnant output despite significant industry efforts to improve efficiency.
- Increasing demand from healthcare providers for demonstrable value and superior efficacy of new drugs compared to existing treatments.
Purpose of the Study:
- To explore the potential of Big Data initiatives in addressing the productivity challenges within the pharmaceutical industry.
- To identify how integrating disparate data sources can provide critical insights for industry growth.
- To examine the role of Big Data in enhancing the value proposition of new pharmaceutical products.
Main Methods:
- Implementation of Big Data strategies.
- Integration of data from diverse sources and disciplines within the life sciences.
- Analysis of data to identify trends and opportunities for productivity improvement.
Main Results:
- Identification of Big Data as a new frontier for the pharmaceutical industry.
- Potential for Big Data to provide insights for overcoming productivity challenges.
- Prospect of returning the industry to sustainable growth through data-driven strategies.
Conclusions:
- Big Data integration is a promising strategy to revitalize the pharmaceutical industry.
- Leveraging diverse life science data can lead to improved efficiency and innovation.
- Addressing healthcare provider demands for value and evidence is crucial for future success.
Related Concept Videos
01:26Drug Discovery: Overview
13.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K
01:28Structure-Activity Relationships and Drug Design
2.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
510
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
510
01:28Preclinical Development: Overview
6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
575
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
575